"non small cell lung cancer" trang 13 - tải miễn phí từ Tailieuchung
Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion

Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion
9    17    1
Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: A Canadian population-based real-world analysis

Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: A Canadian population-based real-world analysis
12    7    1
Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: A prospective and single arm study (DANCE study)

Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: A prospective and single arm study (DANCE study)
6    9    1
Is lobectomy superior to sub-lobectomy in non-small cell lung cancer with pleural invasion? A population-based competing risk analysis

Is lobectomy superior to sub-lobectomy in non-small cell lung cancer with pleural invasion? A population-based competing risk analysis
12    8    1
Molecular pathology testing for non-small cell lung cancer: An observational study of elements currently present in request forms and result reports and the opinion of different stakeholders

Molecular pathology testing for non-small cell lung cancer: An observational study of elements currently present in request forms and result reports and the opinion of different stakeholders
20    11    1
Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis

Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis
13    9    1
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice

Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
10    9    1
The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-TKI therapy

The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-TKI therapy
13    13    1
Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer

Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer
11    2    1
Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: A SEER cohort-based study

Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: A SEER cohort-based study
14    16    1
Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first line tyrosine kinase inhibitors: Brain metastasis and de novo T790M matters

Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first line tyrosine kinase inhibitors: Brain metastasis and de novo T790M matters
11    10    1
Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds

Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds
12    25    1
LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR433-3p to upregulate WTAP

LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR433-3p to upregulate WTAP
11    29    1
A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer

A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer
8    74    0
Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study

Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study
10    41    0
Modulation the crosstalk between tumorassociated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2

Modulation the crosstalk between tumorassociated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2
12    54    1
A phase II study of Endostatin in combination with paclitaxel, carboplatin, and radiotherapy in patients with unresectable locally advanced non-small cell lung cancer

A phase II study of Endostatin in combination with paclitaxel, carboplatin, and radiotherapy in patients with unresectable locally advanced non-small cell lung cancer
7    45    1
Significant correlation between urinary N1 , N12-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer

Significant correlation between urinary N1 , N12-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer
8    32    1
Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: An economic analysis

Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: An economic analysis
11    44    1
Extraordinary response to crizotinib in a woman with squamous cell lung cancer after two courses of failed chemotherapy

Extraordinary response to crizotinib in a woman with squamous cell lung cancer after two courses of failed chemotherapy
4    33    5
TAILIEUCHUNG - Chia sẻ tài liệu không giới hạn
Địa chỉ : 444 Hoang Hoa Tham, Hanoi, Viet Nam
Website : tailieuchung.com
Email : tailieuchung20@gmail.com
Tailieuchung.com là thư viện tài liệu trực tuyến, nơi chia sẽ trao đổi hàng triệu tài liệu như luận văn đồ án, sách, giáo trình, đề thi.
Chúng tôi không chịu trách nhiệm liên quan đến các vấn đề bản quyền nội dung tài liệu được thành viên tự nguyện đăng tải lên, nếu phát hiện thấy tài liệu xấu hoặc tài liệu có bản quyền xin hãy email cho chúng tôi.
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.